Literature DB >> 20570423

A physiologic-based approach to the treatment of acute hyperkalemia.

Roman Shingarev1, Michael Allon.   

Abstract

Hyperkalemia is a common and potentially lethal disorder. Given its variable presentation, clinicians should have a high index of suspicion, especially in patients with chronic kidney disease. The present case highlights key physiologic mechanisms in the development of hyperkalemia and provides an outline for emergent treatment. In this context, we discuss specific mechanisms of action of available treatments of hyperkalemia. Copyright (c) 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20570423      PMCID: PMC4028168          DOI: 10.1053/j.ajkd.2010.03.014

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  27 in total

1.  Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients.

Authors:  M Allon; C Copkney
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

2.  Early and late adjustment to potassium loading in humans.

Authors:  T J Rabelink; H A Koomans; R J Hené; E J Dorhout Mees
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

3.  Effect of chronic renal failure on Na,K-ATPase alpha 1 and alpha 2 mRNA transcription in rat skeletal muscle.

Authors:  S Bonilla; I A Goecke; S Bozzo; M Alvo; L Michea; E T Marusic
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

4.  Modulation of the secretion of potassium by accompanying anions in humans.

Authors:  E J Carlisle; S M Donnelly; J H Ethier; S E Quaggin; U B Kaiser; S Vasuvattakul; K S Kamel; M L Halperin
Journal:  Kidney Int       Date:  1991-06       Impact factor: 10.612

5.  Active Na-K transport and the rate of ouabain binding. The effect of insulin and other stimuli on skeletal muscle and adipocytes.

Authors:  T Clausen; O Hansen
Journal:  J Physiol       Date:  1977-09       Impact factor: 5.182

6.  Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease.

Authors:  R Gutierrez; F Schlessinger; J R Oster; B Rietberg; G O Perez
Journal:  Miner Electrolyte Metab       Date:  1991

7.  Resin treatment of hyperkalemia. I. Exchange properties of a cation exchange resin (calcium cycle).

Authors:  P P Frohnert; W J Johnson; G J Mueller; W N Tauxe; J T McCall
Journal:  J Lab Clin Med       Date:  1968-05

8.  Beta adrenergic control of extrarenal potassium disposal. A beta-2 mediated phenomenon.

Authors:  M J Bia; D Lu; K Tyler; R A De Fronzo
Journal:  Nephron       Date:  1986       Impact factor: 2.847

9.  Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog.

Authors:  J H Pratt
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

10.  Potassium-lowering effect of albuterol for hyperkalemia in renal failure.

Authors:  J Montoliu; X M Lens; L Revert
Journal:  Arch Intern Med       Date:  1987-04
View more
  3 in total

1.  Cation Exchange Resins and colonic perforation. What surgeons need to know.

Authors:  María Rita Rodríguez-Luna; Enrique Fernández-Rivera; Joaquín E Guarneros-Zárate; Jorge Tueme-Izaguirre; José Roberto Hernández-Méndez
Journal:  Int J Surg Case Rep       Date:  2015-09-28

2.  Surprising Hyperkalemia of 10.2 mmol/L in a Patient with Hyperglycemia: A Case Report.

Authors:  Jan Czogalla; Pischtaz Adel Tariparast; Tobias B Huber; Matthias Janneck; Florian Grahammer
Journal:  Case Rep Nephrol Dial       Date:  2021-02-25

3.  Differentiating Pseudohyperkalemia From True Hyperkalemia in a Patient With Chronic Lymphocytic Leukemia and Diverticulitis.

Authors:  John Dewey; Joshua Mastenbrook; Laura D Bauler
Journal:  Cureus       Date:  2020-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.